Search Results

Eli Lilly monoclonal antibody drug trial paused over safety concerns

October 20, 2020 - monoclonal antibody research is Regeneron, the company behind the antibody treatment given to President Donald Trump after he tested positive for the coronavirus earlier this month. Trump has promoted these treatments, saying that they helped cure his condition. He has also suggested that government approval for them is imminent.

Both Eli Lilly and Regeneron have applied for emergency clearance from the Food and Drug Administration (FDA), though the former has only ...

Medical scientists cautiously describe 100% CURE for cancer using new monoclonal antibody treatment

June 09, 2022 - monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma," the study reads.

"This treatment was to be followed by standard chemoradiotherapy and surgery."Dostarlimab works all by itself – no chemotherapy necessary

According to the Times, dostarlimab effectively "unmasks cancer cells, allowing the immune system to identify and destroy them." Further cancer treatments such ...

Another 14 states have been cut off from monoclonal antibody treatments, compliments of the Biden regime

April 05, 2022 -

The latest reports show that another 14 states are now prohibited from receiving shipments of sotrovimab, which is manufactured by GlaxoSmithKline (GSK) and Vir Biotechnology.

A March 30 announcement from the Department of Health and Human Services (HHS) indicated that the total number of states that are no longer receiving sotrovimab has reached 22.

The latest 14 states to get the axe include Alaska, Arizona, California, Hawaii, Idaho, Illinois, Indiana, Michigan, ...

Act of civil war? Biden regime cuts supply of life-saving monoclonal antibody in half, targeting red states

January 11, 2022 - monoclonal antibody sites.”

“But for the federal government’s decision to restrict supply of monoclonal antibody treatment to Florida, my administration would have already opened additional monoclonal antibody treatment sites throughout the state,” DeSantis said in a press release.

DeSantis added that before the Biden regime “seized control of the monoclonal supply” the Sunshine State was administering 30,000 doses each week to needy, infected ...

Now New York is refusing monoclonal antibodies for white people

January 04, 2022 - monoclonal antibody treatment said to be effective against the new Omicron (Moronic) variant of the Wuhan coronavirus (Covid-19) is also in short supply.

“There will be a pause on allocations of bamlanivimab and etesevimab together, etesevimab alone, and REGEN-COV beginning 1/3/2022,” the announcement further explains.

Because of all this, the department is limiting availability of these drugs only to non-whites, unless a white person has “a medical condition ...

FDA identifies dozens of inaccurate coronavirus antibody tests

June 01, 2020 -

A total of 27 vendors will no longer be allowed to sell their antibody tests because they haven’t been shown to work. Yesterday, the FDA published a list of the makers whose tests will no longer be marketed or distributed; it’s not known whether they will be facing additional penalties. Many of them appear to be from Chinese companies.

In tests carried out by ABC News and the Mayo Clinic, half of the antibody tests examined were found to be unreliable, with one even saying ...

Biden cuts off America’s supply of monoclonal antibodies – only “vaccines” allowed

January 26, 2022 - monoclonal antibody administration sites are now "closed until further notice," the Florida Department of Health (FDH) tweeted.

"Unfortunately, as a result of this abrupt decision made by the federal government, all monoclonal antibody sites will be closed until further notice," the announcement reads.

"Individuals with appointments have been directly contacted regarding cancellations. If you have tested positive for COVID-19, please contact your ...

AstraZeneca’s experimental “antibody cocktail” fails to prevent coronavirus symptoms

June 21, 2021 -

The trial, named "Storm Chaser," was on Phase III. It involved 1,121 adult volunteers from the United States and the United Kingdom. The vast majority of the volunteers did not have COVID-19 symptoms at the start of the trial. But they were exposed to the coronavirus soon after the trial started.

AstraZeneca claimed the goal of the trial was to figure out whether the long-acting antibody cocktail it developed could protect people who had recently been in contact with coronavirus-positive ...

AstraZeneca begins advanced trials for COVID-19 antibody medication

October 26, 2020 -

The two initial trials for the antibody-drug will assess its ability to prevent infections for as much as a year in some patients. The trials will also explore the drug's use as a preemptive treatment for patients exposed to SARS-CoV-2. Long-acting antibodies such as the ones used in AstraZeneca’s drug mimic the ones found in the human body; these have the potential to halt the effects of COVID-19 in infected patients. AZD7442 could also be used to complement a vaccine against ...

FDA panel unanimously supports new RSV antibody drug for infants

June 14, 2023 -

All 21 members of the FDA's Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favor of the monoclonal antibody nirsevimab on June 8. The committee agreed that the benefits of nirsevimab exceed the dangers in preventing RSV infections for newborns and infants in their initial RSV season. With the AMDAC's decision, nirsevimab is closer to receiving final regulatory approval.

In a separate 19-2 vote, the AMDAC supported the monoclonal antibody's ...

FDA criticized for restricting the use of COVID antibody treatments

January 27, 2022 - monoclonal antibody treatments. While the FDA noted that the drugs are currently not cleared for use in any of the U.S. states or territories, they may be authorized in other regions if proven to work against new variants.

Doctors also have alternate therapies to battle COVID-19 cases, including new antiviral pills from Merck and Pfizer. However, they are currently still in short supply. Another antibody drug from GlaxoSmithKline that is effective against COVID ...

Are monoclonal antibodies an anti-venom to a snake-based component of covid?

April 12, 2022 -

In a bombshell interview with Mike Adams, the Health Ranger – watch below – Dr. Bryan Ardis unpacked new revelations that are not exactly new, but that were never widely reported. Because of this, most people are not even aware of the snake connection.

On Dec. 1, 2021, after months of going around warning about the potential dangers of monoclonal antibodies as an early treatment for the Fauci Flu, Dr. Ardis received a text from a medical doctor that at first appeared random....

American Journal host Harrison Smith slams “racist” monoclonal antibodies treatment for COVID-19

January 12, 2022 -

Smith, host of the "American Journal" on the InfoWars network, tweeted on Nov. 14 last year that he was denied receiving monoclonal antibody treatment for the Wuhan coronavirus (COVID-19) because he was White and the said treatment was only available for Blacks and Hispanics. He was also able to produce a video clearly showing a medical staff telling him that only reason for his rejection is his ethnicity.

According to Smith, he tried to avail of the monoclonal ...

Texas health systems discriminating against white people, denying them access to monoclonal antibodies

December 30, 2021 -

Because young and middle-aged white people are considered less at risk than pretty much all other demographics when it comes to the Fauci Flu, MMC believes that only non-whites, the obese and the immunocompromised should be eligible for the infusion.

The MMC website explains that in order to qualify for monoclonal antibody treatment, a patient must meet at least one of the following criteria:

• Pregnancy

• High-risk ethnicity group (Hispanic or black)

• ...

This Ayurvedic herb can regulate immune function and stimulate antibody production

April 20, 2021 -

Besides skin conditions, herbal medicines containing black cutch extracts are used to treat a wide variety of diseases, including asthma, bronchitis, colic, diarrhea, ulcers, anemia and stomatitis (mouth inflammation). Recent studies have also found that the bark, heartwood and sap of this useful plant have many pharmaceutical properties, such as anthelmintic, antihyperglycemic, antipyretic and anti-inflammatory activities.

In a recent study, researchers at Mahatma Gandhi ...

Doubts raised on effectiveness of coronavirus antibody testing in the UK

July 15, 2020 -

According to a review of studies conducted by Cochrane, a U.K.-based network that assesses health research to help direct policy, roughly one in 10 antibody tests will miss cases of COVID-19. This could lead to people making harmful decisions delaying treatment or even traveling.

“There is no decision [patients] should be making based on the results of a test,” stated the review’s lead author Jon Deeks, a professor of biostatistics at Birmingham University in England. “We ...

Dr. Mary Talley Bowden: IVERMECTIN as effective as monoclonal antibodies against COVID-19 – Brighteon.TV

May 02, 2023 -

She expounded on this during the April 24 episode of the Brighteon.TV program "America Can We Talk?" with Debbie Georgatos. Bowden said she started offering monoclonal antibodies to patients when they first came out. The physician attested to the efficacy of this treatment as her patients infected with COVID-19 managed to recover within 24 hours.

At the time, Bowden had an unlimited supply of monoclonal antibodies since she could go straight to the manufacturer and order ...

Now Utah is discriminating against White people, denying them monoclonal antibodies as covid treatment

January 14, 2022 -

A 25-year-old whose parents were born in Cuba, for example, can now be offered monoclonal antibodies instead of a 62-year-old "white race" American simply due to skin color.

This "progressive" guideline can be found on Page 6 of Utah's Monoclonal Antibody Allocation Guidelines document.

Some health systems in Texas are doing the same thing by sending non-whites to the front of the line, while whites are told to get to the back of the bus.

Certain ...

FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment

November 12, 2020 -

The FDA extended the emergency approval to the experimental therapy known as “bamlanivimab.” It may be given to people 12 years old and older who have mild to moderate cases of the coronavirus and have not visited the emergency room or have been admitted to a hospital. Bamlanivimab is a one-time treatment that is administered through an IV.

In a statement, FDA Commissioner Stephen M. Hahn gave his support for the approval of bamlanivimab.Bamlanivimab is known ...

Covid “negative” patients are overwhelming hospitals, exactly as predicted with Antibody Dependent Enhancement

November 10, 2021 -

According to the talking-heads, these people do not have the Wuhan coronavirus (Covid-19) because many of them are "fully vaccinated," so the whole thing is a "mystery," they claim.

Since the jabs are "safe and effective," there is no explanation for this latest crisis. It must just be a coincidence, right?

"ERs are now swamped with seriously ill patients – but many don't even have covid," reported Michigan Radio.

NPR also relayed the story, pretending ...